TL;DR
Get workout gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
MedPage Today published a weekly roundup of remarks from clinicians and researchers on Oct. 18, 2026. The comments covered healthcare AI, an mRNA flu shot, pregnancy medication safety, transplant measures, HIV care and other topics; the roundup itself does not report new study results or policy decisions.
MedPage Today published a weekly roundup on Oct. 18 collecting comments its reporters heard on healthcare technology, medicines, research and clinical care. The quotations include a warning from UC Berkeley Labor Center researcher Mishal Khan that technology is not neutral, alongside remarks about an mRNA flu shot, pregnancy medication safety, transplant measures and HIV treatment; the roundup is a collection of comments, not a report of new findings in itself.
Khan, a PhD researcher at the UC Berkeley Labor Center, was quoted discussing artificial intelligence in healthcare: “Tech is not good or bad, but neither is it neutral.” The comment frames technology as something shaped by the settings in which it is designed and used. The roundup does not give further details about the specific AI system or research that prompted the remark.
Other comments address access and interpretation of evidence. Amesh Adalja of the Johns Hopkins Center for Health Security said people seeking the mRNA flu shot mFlusiva would need to use its website or call around. Krista Huybrechts of Brigham and Women’s Hospital described findings on benzodiazepine use early in pregnancy as reassuring, while cautioning that the drugs are not risk-free. The roundup does not provide the study methods or numerical results behind that characterization.
The collection also includes remarks on pulmonary vascular resistance after heart transplantation, cancer risk among people with sickle cell disease, long-acting HIV therapy, and screening for pediatric obesity. The speakers emphasized interpreting measures in context, distinguishing what evidence establishes from what remains unproven, and recognizing that people with similar body mass index readings can have different health profiles. A separate comment from plastic surgeon Kelly Killeen criticized the approach represented by the early-2000s reality show “The Swan.”
How the Quotes Frame Health Decisions
The roundup’s value is in capturing how clinicians and researchers describe evidence and care, rather than announcing a single clinical breakthrough. Across the remarks, speakers caution against treating a technology, test result or risk estimate as self-explanatory. That is relevant to patients and health professionals weighing tools or findings whose effects depend on the population, care setting and wider circumstances.
Khan’s point about AI, for example, puts attention on the choices surrounding healthcare technology, not just its technical capabilities. The comments on benzodiazepines and pregnancy similarly distinguish reassuring study findings from a claim of no risk. These are speakers’ characterizations in a short roundup; readers would need the underlying studies and reporting to judge the evidence and its limits.
AI-assisted healthcare decision tools
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
A Weekly Collection, Not One Study
MedPage Today describes the item as quotable remarks heard by its reporters. It brings together comments on separate topics rather than presenting a unified investigation. The statements concern different studies, clinical questions and public-facing issues, and they should not be read as findings from one research project.
The source lists each speaker’s name and professional affiliation, including researchers and physicians from universities, hospitals and medical organizations. It gives brief descriptions of the subjects they were discussing, but does not supply full interviews, study citations, publication dates for the referenced research or detailed methods. The roundup was published on October 18, 2026, and is labeled as a two-minute read.
““Tech is not good or bad, but neither is it neutral.””
— Mishal Khan, PhD, UC Berkeley Labor Center
Details Behind the Remarks
The roundup does not identify the exact AI application behind Khan’s comment or give enough information to evaluate how it is being used. It also does not specify the website, access arrangements or distribution details for mFlusiva. Readers cannot determine from the item alone how widely the shot is available or what alternatives are offered.
For the research-related comments, the source provides no study titles, sample sizes, effect estimates or full conclusions. Huybrechts’s description of findings as reassuring is attributed to her and should not be taken to mean that benzodiazepines are risk-free. The roundup likewise does not establish the scale of cancer risk in sickle cell disease, the results of the transplant analysis, or the outcomes associated with long-acting HIV therapy. Those questions require the underlying research and its full reporting.
Follow the Studies and Access Updates
MedPage Today’s item does not announce a follow-up date or a single next milestone. For readers seeking more detail, the next step is to consult the original coverage and research associated with each comment, including study methods, results and limitations. Information about mFlusiva access would need to come from the relevant provider or official product and distribution sources.
Further reporting could clarify how the cited findings may affect clinical practice and whether access to the flu shot changes. Until those details are available, the roundup is best read as a snapshot of remarks from separate health stories, with the claims attributed to the people who made them.
Key Questions
What did MedPage Today publish?
It published a weekly collection of quotations heard by its reporters, covering healthcare AI, medicines, research and clinical care. The roundup appeared on October 18, 2026.
Was the item a new research report?
No. It is a recap of comments about separate topics. It does not present a new study or provide the detailed results of the research mentioned.
What did the roundup say about AI in healthcare?
Mishal Khan of the UC Berkeley Labor Center said, “Tech is not good or bad, but neither is it neutral.” MedPage Today identifies the subject as healthcare AI but does not specify the system or application being discussed.
Did the roundup say benzodiazepines are safe during pregnancy?
No. Krista Huybrechts described findings from a study on early-pregnancy use and congenital malformations as reassuring, while stating that benzodiazepines are not risk-free. The roundup does not provide the study’s numerical results or full conclusions.
What remains unknown about mFlusiva access?
Amesh Adalja said people seeking the mRNA flu shot would need to use its website or call around. The item does not specify its availability, distribution area, eligibility rules or other access options.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
